JPWO2021215517A1 - - Google Patents

Info

Publication number
JPWO2021215517A1
JPWO2021215517A1 JP2022517104A JP2022517104A JPWO2021215517A1 JP WO2021215517 A1 JPWO2021215517 A1 JP WO2021215517A1 JP 2022517104 A JP2022517104 A JP 2022517104A JP 2022517104 A JP2022517104 A JP 2022517104A JP WO2021215517 A1 JPWO2021215517 A1 JP WO2021215517A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022517104A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021215517A1 publication Critical patent/JPWO2021215517A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2022517104A 2020-04-22 2021-04-22 Pending JPWO2021215517A1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020076370 2020-04-22
JP2020174820 2020-10-16
PCT/JP2021/016372 WO2021215517A1 (ja) 2020-04-22 2021-04-22 新型コロナウイルス感染症（ｃｏｖｉｄ－１９）の治療及び／又は予防剤

Publications (1)

Publication Number Publication Date
JPWO2021215517A1 true JPWO2021215517A1 (ja) 2021-10-28

Family

ID=78269312

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021072865A Active JP7058026B2 (ja) 2020-04-22 2021-04-22 新型コロナウイルス感染症（ｃｏｖｉｄ－１９）の治療及び／又は予防剤
JP2022517104A Pending JPWO2021215517A1 (ja) 2020-04-22 2021-04-22

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021072865A Active JP7058026B2 (ja) 2020-04-22 2021-04-22 新型コロナウイルス感染症（ｃｏｖｉｄ－１９）の治療及び／又は予防剤

Country Status (5)

Country Link
US (1) US20230190690A1 (ja)
EP (1) EP4140479A4 (ja)
JP (2) JP7058026B2 (ja)
CN (1) CN115768415A (ja)
WO (1) WO2021215517A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101478237B1 (ko) * 2013-05-13 2014-12-31 주식회사 시온테크 선박용 굴뚝의 사다리 구조체

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895786A (en) * 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
MXPA05008298A (es) 2003-02-04 2005-09-20 Yakult Honsha Kk Inhibidor de la proteina de resistencia a cancer de mama.
CA2515135A1 (en) 2003-02-04 2004-08-19 Kabushiki Kaisha Yakult Honsha Breast cancer-resistant protein inhibitor
EA014555B1 (ru) 2005-03-30 2010-12-30 Кабусики Кайся Якулт Хонса Ингибитор bcrp/abcg2
TW200927107A (en) 2007-12-03 2009-07-01 Yakult Honsha Kk ABCG2 inhibitor
US9351949B2 (en) * 2012-07-19 2016-05-31 Sbi Pharmaceuticals Co., Ltd. Prophylactic/therapeutic agent for influenza virus infection
AU2014283588A1 (en) 2013-06-18 2015-11-05 Nestec S.A. Filter unit for a capsule
EP3281629A1 (en) * 2015-04-10 2018-02-14 SBI Pharmaceuticals Co., Ltd. Prophylactic/therapeutic agent for virus infections which comprises ala compound
TW202106293A (zh) * 2019-04-26 2021-02-16 日商日本紐翱醫藥股份有限公司 黃病毒（ｆｌａｖｉｖｉｒｕｓ）感染症治療劑
US10987329B1 (en) 2020-04-22 2021-04-27 Nadimpally Satyavarahala Raju Combination therapy for coronavirus infections including the novel corona virus (COVID-19)
US11883376B2 (en) 2020-04-22 2024-01-30 Nadimpally Satyavarahala Raju Viral infection treatment with 5-aminolevulinic acid

Also Published As

Publication number Publication date
US20230190690A1 (en) 2023-06-22
EP4140479A1 (en) 2023-03-01
JP2022008060A (ja) 2022-01-13
WO2021215517A1 (ja) 2021-10-28
CN115768415A (zh) 2023-03-07
JP7058026B2 (ja) 2022-04-21
EP4140479A4 (en) 2024-05-29

Similar Documents

Publication Publication Date Title
BR112021014123A2 (ja)
BR112023012656A2 (ja)
BR102021018859A2 (ja)
BR102021015500A2 (ja)
JPWO2021215517A1 (ja)
BR102021007058A2 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023011539A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016200A2 (ja)
BR102021016176A2 (ja)
BR102021015566A2 (ja)
BR102021015450A8 (ja)
BR102021015247A2 (ja)
BR102021015220A2 (ja)
BR102021014044A2 (ja)
BR102021014056A2 (ja)
BR102021013929A2 (ja)
BR102021012571A2 (ja)